All Emblaveo articles

  • shutterstock_1725267103
    News

    CHMP meeting highlights: March 2024

    2024-03-26T15:48:53Z

    At the Committee for Medicinal Products for Human Use (CHMP)’s March meeting, twelve medicines received positive opinions for marketing authorisations, including a new antibiotic and a novel oral medicine for a rare blood disorder.

  • shutterstock_1042543318
    News

    Positive CHMP recommendation for antibiotic combination

    2024-03-25T12:27:35Z

    EMA has recommended granting a marketing authorisation for Emblaveo for treatment of infections caused by multidrug-resistant bacteria.